Records of the placental transfer of the lupus erythematosus factor are scanty. We have been able to find two cases only in the literature (Bridge and Foley, 1954) . They described a case where a woman suffering from acute systemic lupus erythematosus was successfully delivered of a normal child. The child remained clinically well, but the characteristic L.E. cells described by Hargraves, Richmond, and Morton (1948) were demonstrated in the blood at birth. The test gave a doubtful result after seven weeks and was negative at four months. They mention one other similar case but give no details.
The production of these cells is now recognized as due to a factor associated with the gammaglobulin fraction of the plasma. An instance is described where this plasma factor was present in the blood of a foetus aged 20 weeks, whose mother suffered from subacute systemic lupus erythematosus. Presumably this was the result of passive transfer of the L.E. factor across the placenta, since at necropsy the foetus showed no evidence of the disease.
Case Report
The patient was a 30-year-old housewife who was quite well until June, 1952, when Examination of the blood from the umbilical vein of the foetus showed occasional L.E. cells (less than I per 1,000 white cells) and the direct Coombs test was positive in five minutes. Both the Kahn and Wassermann reactions were negative. Filter-paper electrophoresis showed a heavy gamma globulin band in the mother's serum, but this was absent in the amniotic fluid and in the foetal serum.
At necropsy, the foetus appeared normal for the period of gestation with no evidence of the characteristic fibrinoid necrosis in the arterioles or connective tissue of the body including the spleen, kidneys, myocardium, skin, and placenta.
The Table) . These results can be explained by passive transfer across the placenta, but the antibodies responsible for these different phenomena appear to cross the placental barrier independently of one another. The transfer of the factor producing a positive direct Coombs test in this condition may obviously cause difficulty in the diagnosis of haemolytic disease of the newborn.
To decide whether to terminate pregnancy in a case of systemic lupus erythematosus is difficult. Many cases start during pregnancy (Guion and Adams, 1943; Graffin, Taylor, and Hass, 1949; Ellis and Bereston, 1952: Smith. 1952; Cohen and Cadman, 1953; Harvey, Shulman, Tumulty, Conley, and Schoenrich, 1954) . Moreover, Ellis and Bereston (1952) found that the disease became worse during pregnancy in 28 out of 69 cases. The disease started in our patient during her first pregnancy and became worse during the early weeks of her second. However, some cases improve during pregnancy but become worse in the puerperium (Guy, 1952; Harvey et al., 1954) . From a study of the literature only one factor has been discovered which allows a prediction of the effect of pregnancy, or its termination, on the disease: this is the effect of a previous pregnancy. For instance, Rothman (1952) cites a case in which symptoms recurred during the first trimester of three successive pregnancies followed by rapid improvement after abortion, which was either spontaneous or induced therapeutically. This patient, like that reported by Shearn and Pirofsky (1952) , improved, but Harvey et al. (1954) report cases in which therapeutic abortion led to no improvement.
Although antibodies have been found in the foetus on two previous occasions when systemic lupus erythematosus occurs during pregnancy, no characteristic pathological changes have yet been reported. The high rate of foetal loss (32%) reported by Ellis and Bereston (1952) would thus appear to be due to maternal causes, rather than to a direct effect of the disease on the foetus.
We wish to thank Dr. N. S. Plummer for permission to study this patient and for much helpful advice and criticism, and Dr. John Shore for his necropsy report.
Addendum
Since submitting this article Berlyne, Short, and Vickers (1957) have described two further instances of placental transfer of the L.E. factor. In both cases L.E. cells were demonstrable in mother and foetus. The infants remained healthy, L.E. cells disappearing from the blood by seven weeks. 
